About Jell Pharmaceuticals
Jell Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 1996. It offers contract-based drug manufacturing and marketing services in pharmaceuticals. It operates on a B2B model. The company has 222 employees. Its Indian entity Jell Pharmaceuticals Private Limited reported revenue of ₹459 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Contract Services. Its competitors include Mamaearth, MyGlamm, L'Occitane, Minimalist and The Ayurveda Experience and 2 more; 7 of its 7 listed competitors have raised funding.
Company details
Jell Pharmaceuticals offers contract-based drug manufacturing and marketing services in pharmaceuticals through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and contract services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- Employees 222
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website jellpharma.com
- Social LinkedIn
- Legal Name Jell Pharmaceuticals Private Limited
- Date of Incorporation 31 Aug, 1994
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹459 Cr
FY 2023 · +8% YoY
- Net Profit₹12.56 Cr
FY 2023
- EBITDA₹23.76 Cr
FY 2023
- Employee Count222
Associated legal entities of Jell Pharmaceuticals
Jell Pharmaceuticals operates through Jell Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jell Pharmaceuticals Private Limited CIN U23200MH1994PTC080671 | Active | 31 Aug 1994 | Mumbai, Maharashtra | ₹459 Cr | 222 | 2 | View details |
Board of directors of Jell Pharmaceuticals Private Limited (Jell Pharmaceuticals)
Jell Pharmaceuticals Private Limited is the primary company behind Jell Pharmaceuticals. The board of Jell Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Sanjay Chandrakant Mehta, appointed in 1994. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjay Chandrakant Mehta DIN 01619250 | Whole-time director | 31 Aug 1994 | 32 yrs 1 mo | Jell Pharmaceuticals Private Limited |
| Chirag Chandrakant Mehta DIN 02014258 | Whole-time director | 31 Aug 1994 | 32 yrs 1 mo | Jell Pharmaceuticals Private Limited |
Financials of Jell Pharmaceuticals
Figures of Jell Pharmaceuticals Private Limited, the primary company behind Jell Pharmaceuticals, for FY 2023. Revenue was ₹459 Cr (+8% year on year). Net profit was ₹12.56 Cr. EBITDA was ₹23.76 Cr. Revenue has grown at a compounded annual rate of +23% over three years and +17% over five years.
- ₹459 CrRevenue · FY 2023 · +8% YoY
- ₹12.56 CrNet profit
- ₹23.76 CrEBITDA
- ₹1.00 CrPaid-up capital
- 222Employees (provident fund records)
- +23%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Jell Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Jell Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Jell Pharmaceuticals
Jell Pharmaceuticals has 7 listed competitors in our database, 7 of them funded. They include Mamaearth, MyGlamm, L'Occitane, Minimalist and The Ayurveda Experience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mamaearth.in | 2016 | Gurugram, India | $89.36M | 1,900 | Online brand offering multi-category natural skin care and makeup products | |
| myglamm.com | 2015 | Mumbai, India | $105.68M | 411 | Online platform selling beauty products, makeup, skincare, and cosmetics in India. | |
| loccitane.com | 1976 | Paris, France | $10M | – | Beauty and personal care products are sold by L'Occitane globally. | |
| beminimalist.co | 2018 | Jaipur, India | $17.02M | 545 | Manufacturer of skincare, haircare, and baby care products addressing various skin and hair concerns | |
| theayurvedaexperience.com | 2010 | Singapore | $33M | – | Provides online sales of Ayurvedic face, body, hair care, and educational resources. | |
| buywow.in | 2014 | Bengaluru, India | $98M | 100 | Organic beauty products are offered by an internet-first brand. | |
| plumgoodness.com | 2013 | Thane, India | $103.79M | 293 | Vegan skincare, haircare, and body care products are provided. |
Detailed competitors of Jell Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Jell Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jell Pharmaceuticals
Complete news archive for Jell Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jell Pharmaceuticals
Jell Pharmaceuticals was founded in 1996.
Jell Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Jell Pharmaceuticals has 222 employees.
The primary company behind Jell Pharmaceuticals, Jell Pharmaceuticals Private Limited, reported revenue of ₹459 Cr for FY 2023, up 8% year on year.
Jell Pharmaceuticals offers contract-based drug manufacturing and marketing services in pharmaceuticals through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and contract services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Jell Pharmaceuticals's top competitors include MyGlamm, Mamaearth and L'Occitane.
Jell Pharmaceuticals operates through Jell Pharmaceuticals Private Limited.
The legal entities of Jell Pharmaceuticals currently have 2 directors, including Sanjay Chandrakant Mehta, Chirag Chandrakant Mehta.